Correlation Between Vita Coco and Biodexa Pharmaceticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vita Coco and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vita Coco and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vita Coco and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Vita Coco and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vita Coco with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vita Coco and Biodexa Pharmaceticals.

Diversification Opportunities for Vita Coco and Biodexa Pharmaceticals

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vita and Biodexa is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Vita Coco and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Vita Coco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vita Coco are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Vita Coco i.e., Vita Coco and Biodexa Pharmaceticals go up and down completely randomly.

Pair Corralation between Vita Coco and Biodexa Pharmaceticals

Given the investment horizon of 90 days Vita Coco is expected to generate 0.23 times more return on investment than Biodexa Pharmaceticals. However, Vita Coco is 4.31 times less risky than Biodexa Pharmaceticals. It trades about 0.08 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.06 per unit of risk. If you would invest  1,395  in Vita Coco on September 16, 2024 and sell it today you would earn a total of  2,277  from holding Vita Coco or generate 163.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vita Coco  vs.  Biodexa Pharmaceticals

 Performance 
       Timeline  
Vita Coco 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vita Coco are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Vita Coco displayed solid returns over the last few months and may actually be approaching a breakup point.
Biodexa Pharmaceticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biodexa Pharmaceticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vita Coco and Biodexa Pharmaceticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vita Coco and Biodexa Pharmaceticals

The main advantage of trading using opposite Vita Coco and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vita Coco position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.
The idea behind Vita Coco and Biodexa Pharmaceticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities